Why GLP-1?

Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Trusted brands in one place

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
What Does 'Ozempic for eBay' Actually Mean?
News & Updates

What Does 'Ozempic for eBay' Actually Mean?

When a billionaire investor says eBay "needs to be on Ozempic," it signals how deeply semaglutide has entered the cultural conversation. But for real patients, the more important question is what this attention means for access, cost, and treatment options in 2025 and beyond.

Read More
Food Noise and GLP-1s: What's Really Happening
Patient Guides

Food Noise and GLP-1s: What's Really Happening

Many GLP-1 users report that one of the most powerful effects of their medication isn't the appetite suppression - it's the sudden mental quiet. "Food noise," the constant mental chatter about eating, fades for many patients on semaglutide or tirzepatide. Here's what the science says and what it means for you.

Read More
Oral Wegovy Scripts Drop: What It Means for You
Patient Guides

Oral Wegovy Scripts Drop: What It Means for You

Prescriptions for the oral form of Wegovy (semaglutide pill) have declined for the first time since launch. We break down what's driving this trend, how it compares to injectable options, and what patients should consider before choosing between pill and injection formats.

Read More
Dietitian-Led Care and GLP-1s: What New Guidance Means
GLP-1 Agonists

Dietitian-Led Care and GLP-1s: What New Guidance Means

New obesity treatment guidance is pushing for dietitian-led care to work alongside GLP-1 medications like semaglutide and tirzepatide. If you're on or considering a GLP-1 drug, this shift could change how your care is structured and what to ask your provider. Here's what patients need to know.

Read More
Oral Wegovy Scripts Drop: What It Means for You
GLP-1 Agonists

Oral Wegovy Scripts Drop: What It Means for You

Oral semaglutide prescriptions for Wegovy dropped for the first time, raising questions about patient preferences, cost, and effectiveness compared to injectable GLP-1s. If you're weighing your options, here's what this trend actually tells you and what questions to bring to your doctor.

Read More
GLP-1 Dosing Issues: What Patients Must Know
GLP-1 Agonists

GLP-1 Dosing Issues: What Patients Must Know

Dosing errors with GLP-1 medications like semaglutide and tirzepatide are drawing increased attention from medical experts. Whether you're on a branded drug or a compounded version, getting the dose right is critical for both safety and results. Here's what you need to know to protect yourself.

Read More
Oral Semaglutide Scripts Drop: What It Means
GLP-1 Agonists

Oral Semaglutide Scripts Drop: What It Means

Prescriptions for the oral Wegovy pill declined for the first time, raising questions about patient preferences and the real-world performance of oral GLP-1 medications. Here is what the data means for anyone weighing injectable versus pill-form options and how to make the best choice for your situation.

Read More
GLP-1 Drugs and Muscle Loss: What You Need to Know
GLP-1 Agonists

GLP-1 Drugs and Muscle Loss: What You Need to Know

GLP-1 medications help millions lose weight, but some patients and researchers are asking whether that weight loss comes at the cost of muscle strength. A new study out of St. Louis is investigating this question directly. Here's what current evidence shows and what you can do about it right now.

Read More
Wegovy and Migraines: What Women Should Know
Women's Health

Wegovy and Migraines: What Women Should Know

A new study suggests that starting Wegovy (semaglutide) may reduce migraine medication use by about 8% in women after one year. If you live with both obesity and chronic migraines, this finding could influence how you and your doctor approach treatment. Here's what the research shows and what questions to bring to your next appointment.

Read More